Delivery Order SPE2DB20D3103-SPE2DB25FP7W0
Award Date 8/7/25
Potential Completion Date 8/8/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulvestrant 250 mg/5 mL syringes (5 mL quantity) with a contract ceiling value of $1,224.00. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and was awarded competitively without set-aside restrictions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Fulvestrant 250 mg/5 ml syringes, with a ceiling value of $1,833.12 and a period of performance through May 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 22, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply FULPHILA 6 mg/0.6 mL syringes with a contract value of $10,523.70. The delivery order is structured as a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. Performance of this delivery order will be completed by July 23, 2025, at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Fulphila 6 mg/0.6 ml syringes valued at $6,205.73, with completion expected by July 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery under AmerisourceBergen's larger federal...
- This delivery order, awarded on July 31, 2025, represents a $5,962.48 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026, is scheduled for completion by August 1, 2025. This delivery order was competitively awarded with no set-aside designation and will be...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on July 28, 2025, valued at $13,817.42 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside, competitively awarded delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,440.70 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,392.44 from the Defense Logistics Agency's Medical Supply Chain on August 8, 2025. This contract, designated as a child order under a larger vehicle, carries a firm fixed price structure with an ultimate completion date of August 11, 2025. The award represents a competitively awarded, non-set-aside transaction for pharmaceutical products and...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,590.98 to AmerisourceBergen Drug Corp on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, calls for pharmaceutical and medical supply deliveries to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...